Active Ingredient History
Human serum albumin is the serum albumin found in human blood. It is the most abundant protein in human blood plasma; it constitutes about half of serum protein. It is produced in the liver. It is soluble in water, and it is monomeric. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Burns (approved 1942)
Abortion, Habitual (Phase 2)
Abortion, Spontaneous (Phase 2)
Acute Kidney Injury (Phase 4)
Acute Lung Injury (Phase 3)
Acute-On-Chronic Liver Failure (Phase 4)
Adrenoleukodystrophy (Phase 2/Phase 3)
alpha 1-Antitrypsin Deficiency (Phase 2)
Alzheimer Disease (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 2)
Anastomotic Leak (Phase 2)
Ascites (Phase 4)
Bacterial Infections (Phase 4)
Blood Loss, Surgical (Phase 4)
Body Fluids (Phase 4)
Bronchoscopy (Phase 4)
Burns (Phase 4)
Carcinoma, Hepatocellular (Phase 3)
Cardiomyopathies (Phase 3)
Cardiopulmonary Bypass (Phase 4)
Cardiovascular Diseases (Phase 2)
Cerebral Hemorrhage (Phase 2)
Cerebral Infarction (Phase 2)
Chickenpox (Phase 3)
Cholangitis (Phase 4)
Community-Acquired Infections (Phase 3)
Consciousness Disorders (Phase 4)
Coronary Artery Disease (Phase 4)
COVID-19 (Phase 2)
Delivery, Obstetric (Phase 4)
Dermatology (Phase 3)
Diabetes Mellitus (Phase 2)
Edema (Phase 4)
Endothelium (Phase 4)
Fertilization in Vitro (Phase 2)
Fibrosis (Phase 4)
Gastric Emptying (Phase 2)
Gastroparesis (Phase 2)
General Surgery (Phase 4)
Graft vs Host Disease (Phase 2/Phase 3)
Head and Neck Neoplasms (Phase 1/Phase 2)
Head Injuries, Closed (Phase 2/Phase 3)
Healthy Volunteers (Phase 1)
Heart Failure, Systolic (Phase 1/Phase 2)
Heart Valve Diseases (Phase 4)
Hemorrhage (Phase 4)
Hepatic Encephalopathy (Phase 4)
Hepatitis B, Chronic (Phase 1/Phase 2)
Hepatorenal Syndrome (Phase 4)
HIV Infections (Phase 1/Phase 2)
Hypoalbuminemia (Phase 4)
Hyponatremia (Phase 4)
Hypoproteinemia (Phase 3)
Hypotension (Phase 4)
Hypovolemia (Phase 4)
Immune System Diseases (Phase 2)
Inflammation (Phase 4)
Intensive Care Units (Phase 1/Phase 2)
Intestinal Neoplasms (Phase 4)
Intraoperative Complications (Phase 4)
Ischemic Stroke (Phase 3)
Kidney Failure, Chronic (Phase 2)
Liver Cirrhosis (Phase 4)
Liver Transplantation (Phase 4)
Macular Degeneration (Phase 2)
Measles (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Mumps (Phase 3)
Nerve Degeneration (Phase 3)
Pancreatectomy (Phase 4)
Pancreatic Fistula (Phase 2)
Pancreatic Neoplasms (Phase 4)
Pancreaticoduodenectomy (Phase 3)
Parvovirus B19, Human (Phase 3)
Peptic Ulcer (Phase 4)
Peritonitis (Phase 4)
Pneumonia (Phase 4)
Polyneuropathies (Phase 1)
Postoperative Complications (Phase 4)
Pressure Ulcer (Phase 1/Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Pulmonary Edema (Phase 4)
Renal Insufficiency (Phase 4)
Renal Replacement Therapy (Phase 2)
Respiratory Distress Syndrome (Phase 4)
Risk Factors (Phase 1/Phase 2)
Rubella (Phase 3)
Scleroderma, Systemic (Phase 2)
Sepsis (Phase 4)
Severe Dengue (Phase 3)
Shock (Phase 4)
Shock, Septic (Phase 4)
Squamous Cell Carcinoma of Head and Neck (Phase 1/Phase 2)
Staphylococcal Infections (Phase 4)
Stomach Neoplasms (Phase 2)
Streptococcal Infections (Phase 4)
Subarachnoid Hemorrhage (Phase 1)
Systemic Inflammatory Response Syndrome (Phase 4)
Thoracic Surgery (Phase 4)
Urination Disorders (Phase 4)
Urogenital Neoplasms (Phase 4)
Urologic Diseases (Phase 2)
Vascular Diseases (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue